“Today we had a working meeting with the representative of the Pan American Health Organization and WHO in Cuba, Dr. Jose Moya,” the company said on Twitter.
Hoy sesionó encuentro de trabajo en la presidencia de BioCubaFarma, con el representante de la OPS / OMS en CUBA, el Doctor José Moya.
El encuentro se desarrolló en un clima favorable y tuvo como objetivo el proceso de reconocimiento de nuestras vacunas Covid-19 por la #OMS.
pic.twitter.com/2UfNQQR8P3
- BioCubaFarma (@BioCubaFarma) September 2, 2021
It is noted that the meeting took place in a favorable atmosphere.
On July 17, the Cuban Abdala coronavirus vaccine, developed by the Cuban Center for Genetic Engineering and Biotechnology (CIGB), was 100% effective in a third phase of trials.